Problematic issues of treatment of patients of reproductive age with functional ovarian cysts

and methods. The study included 104 patients with functional ovarian cysts of reproductive age and 50 healthy women. A general clinical, psychological, sonographic, immunological, molecular genetic examination was conducted. Results. The analysis of the study data revealed the presence of chronic inflammatory diseases of the pelvic organs in 72.83% of the patients, the infection with Ureaplasma spp. in 39.58% of cases, Gardnerella vaginalis – 64.58%, Mycoplasma spp. – in 20.80%, Chlamidia trachomatis– in 23.08%. When conducting an ultrasound study, only 23.08% of patients manage to establish the nature of the cysts of the ovary. There was a high level of personal anxiety in 52.24% of patients Conclusion. The application of our proposed complex therapy of functional ovarian cysts in women of reproductive age showed a high recovery rate and a low relapse rate. Key words: functional ovarian cysts, reproductive age, treatment, prophylaxis, micronized progesterone.

1. Alieva VA, Pervushin YuV. 2015. Modern idea of the microbiota of the human body. National Days of Laboratory Medicine in Russia. Russian Congress of Laboratory Medicine «Laboratory Medicine and Clinical Practice»: materials of the Congress (Moscow, 2015). Moscow:65. 2. Morozova EB, Yakovleva NA. 2015. Bacterial microflora of the urogenital tract and evaluation of antibacterial treatment in women with infertility. Women's health 10 (106):168-170. 3. Vdovichenko YuP, Gopchuk EN. 2012. Inflammatory diseases of the pelvic organs – an integrated approach for effective therapy. Women's Health 4 (70):102-108. 4. Vovk IB, Vdovichenko YuP, Kornatskaya AG. 2017. Tumor-like formations of the ovaries: 242. 5. Gerasimova TV. 2014. Optimization of diagnostis and treatment functional ovary cysts. Medical Aspects of Women's Health 5 (80):65-73. 6. Dubossarskaya ZM. 2010. Problems of reproductive health in terms of perinatal psychology. Medical aspects of woman's health 1 (28):20-29. 7. Malofei YuB, Ryzhavsky BYa. 2011. Effect of Progesterone Administration on Pregnant Female Rats on the Development of the Brain of Their Neonatal Offspring. Far Eastern Medical Journal 2:76-80. 8. Opryshko VI, Nosivets DS. 2015. Sublingual form of progesterone: the need for innovation or the challenges of modern medicine. Women's Health 10 (106):37-42. 9. Boris EN, Sumenko VV, Onishchik LN. 2012. The use of IV fluoroquinolones in the complex therapy of pelvic inflammatory diseases. Women's health 4(70):86-94. 10. Nazarenko TA, Durinyan ER, Revishvili NA. 2010. Modern approaches to the use of progestins in women of reproductive age. Herald of reproductive health 3–4:6-8. 11. Shapoval OS. 2016. Clinico-sonological features in tumor-like formations of ovaries in women of reproductive age. Women's Health 1 (107):137-141. 12. Shirsheva SV, Kuklin EM, Bazhenova AV. 2008. Effect of progesterone on the phagocytic and oxidative activity of monocytes and neutrophils. Bulletin of Perm University. Biology 9(25):87-90. 13. Pyrohova VI, Shurpak SO, Kryvko BJ. 2015. Clinacal aspects of long-term care of endometriosis by progestogen dienogest. Women's health 10(106):20-22. 14. Schyn SY. 2008. Analysis of serum levels of Anti-Mullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein – 3 and follicle-stimulating hormone with respect to age and menopausal status. Journal of Korean Medical Science 23;1:104-110. https://doi.org/10.3346/jkms.2008.23.1.104; PMid:18303208 PMCid:PMC2526482